All Healthcare Life Sciences Pharma articles
-
Special ReportsRegulators are cracking down on PFAS and risk managers must plan accordingly
The effects of PFAS chemicals are yet to be seen as health problems slowly come to light. BHSI’s Javier Villalba, explores the litigation landscape risk managers are facing
-
FeaturesSpotlight on: bird flu and the risk it could spread to humans
The FAO, the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH) are urging countries to work together across sectors to prevent the spread of bird flu
-
Case StudiesHow to manage reshoring risks - a US case study
Former pharma risk manager and current P.E. integrated risk leader at Sigma7, Andrew Tait, looks at how reshoring changes the exposures faced by manufacturing companies in the US, and what global lessons can be learnt
-
OpinionLearning lessons from pharma risk management
Kathrin Anne Meier, Board Member, SRA - Swiss Risk Association, explores how risk managers are tackling the unique threats facing the pharmaceutical industry and what other sectors can learn from their approach
-
AnalysisIs risk getting enough attention in the NHS?
The potential for ”unintended consequences” is high as healthcare systems become more complex - BMJ
-
AnalysisDigital health sector overexposed - survey
More than two thirds lack insurance coverage for bodily injury claims arising from system failure or cyber breach
-
AnalysisHealthcare leads data risk assessments – Trustwave study
UK professionals value their personally identifiable data at less than half as much as their US counterparts, according to a report from tech firm Trustwave
-
AnalysisGermany exempted from mandatory rebates for pharmaceutical companies
The European Commission found that the scheme pursues an objective of common interest
-
AnalysisHealthcare in Africa improves amid Ebola outbreak
International SOS’ analysis reveals the world’s most dangerous locations concerning health risk
-
Online onlyEbola: EU announces medium/long-term support through development co-operation
Efforts should ultimately help contain, control, treat and defeat the disease
-
AnalysisDoes your insurance cover you for Ebola-related claims?
With the disease spreading further and further, corporate policyholders would be wise to assess their insurance coverage
-
Online onlyEU to boost Ebola research with €24.4m
Funding to go to five projects via a fast-track procedure
-
AnalysisQ&A: Ebola and the health implications for the EU
With the number of cases now having reached more than 8,000, the EU has issued a Q&A on the deadly virus
-
AnalysisACE addresses growing casualty exposures in Europe’s life science industry
Insurer aims to support life science firms in Continental Europe with an enhanced proposition that includes catastrophe management
-
AnalysisEbola outbreak could affect supply chains
Businesses need to consider in more detail the wider impact on their operations of outbreaks of infectious diseases
-
FeaturesBusinesses urged to improve continuity plans as Ebola spreads
As Ebola spreads through West Africa, companies with operations in the region should check their continuity plans, but avoid panicking as, although the disease has no cure, their employees are unlikely to catch it
